What 8 Analyst Ratings Have To Say About Gilead Sciences
What 8 Analyst Ratings Have To Say About Gilead Sciences
分析师评级认为吉利德科学的情况如下：
In the last three months, 8 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range of perspectives from bullish to bearish.
过去三个月中，有8个分析师对吉利德科学（纳斯达克：GILD）进行了评级，提供了从看好到看淡的多元化观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $79.5, along with a high estimate of $105.00 and a low estimate of $69.00. A decline of 5.03% from the prior average price target is evident in the current average.
分析师提供更深入的见解，已建立12个月的价格目标，表明平均目标为79.5美元，高估值为105.00美元，低估值为69.00美元。 当前的平均价格目标与之前相比下降了5.03％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
A comprehensive examination of...
对吉利德...
登录免费看全文
登录/注册